Two cases of marked red cell anisopoikilocytosis and haemolysis with alectinib, an anaplastic lymphoma kinase inhibitor

Saved in:
Bibliographic Details
Published in:British journal of haematology 2020-09, Vol.190 (5), p.642-642
Main Authors: Yuan, Yin, Mapp, Sally, Xu, Wen
Format: Article
Language:English
Subjects:
Aged
Anaplastic Lymphoma Kinase - antagonists & inhibitors
Brain Neoplasms - drug therapy
Brain Neoplasms - metabolism
Brain Neoplasms - pathology
Carbazoles - administration & dosage
Carbazoles - adverse effects
Enzyme inhibitors
Erythrocytes - metabolism
Erythrocytes - pathology
Female
Hematology
Hemolysis - drug effects
Humans
Lung Neoplasms - drug therapy
Lung Neoplasms - metabolism
Lung Neoplasms - pathology
Male
Piperidines - administration & dosage
Piperidines - adverse effects
Protein Kinase Inhibitors - administration & dosage
Protein Kinase Inhibitors - adverse effects
Protein-tyrosine kinase
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0007-1048
1365-2141
DOI:10.1111/bjh.16813